ZOLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 11.849
EU - Europa 8.387
AS - Asia 3.524
AF - Africa 478
SA - Sud America 43
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 24.301
Nazione #
US - Stati Uniti d'America 11.816
GB - Regno Unito 2.077
IT - Italia 1.886
VN - Vietnam 1.206
SE - Svezia 1.166
DE - Germania 1.065
CN - Cina 937
SG - Singapore 690
IN - India 472
IE - Irlanda 375
UA - Ucraina 375
FR - Francia 305
RU - Federazione Russa 285
CH - Svizzera 282
TG - Togo 211
EE - Estonia 174
ZA - Sudafrica 168
BG - Bulgaria 141
JO - Giordania 97
CI - Costa d'Avorio 49
NL - Olanda 48
FI - Finlandia 47
BE - Belgio 42
CA - Canada 27
IR - Iran 24
NG - Nigeria 24
GR - Grecia 21
SC - Seychelles 21
JP - Giappone 20
BR - Brasile 17
ES - Italia 15
TR - Turchia 15
AT - Austria 14
AU - Australia 14
PL - Polonia 14
HR - Croazia 13
CL - Cile 12
LB - Libano 11
RO - Romania 11
KR - Corea 8
DK - Danimarca 7
UZ - Uzbekistan 7
PH - Filippine 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
HK - Hong Kong 5
MY - Malesia 5
AR - Argentina 4
IL - Israele 4
MK - Macedonia 4
PE - Perù 4
EC - Ecuador 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
AG - Antigua e Barbuda 2
AL - Albania 2
AZ - Azerbaigian 2
EU - Europa 2
HU - Ungheria 2
LU - Lussemburgo 2
PA - Panama 2
PK - Pakistan 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
ID - Indonesia 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PT - Portogallo 1
RE - Reunion 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 24.301
Città #
Southend 1.880
Fairfield 1.729
Chandler 1.386
Ashburn 1.004
Woodbridge 766
Dong Ket 742
Seattle 704
Wilmington 662
Houston 635
Cambridge 600
Singapore 592
Princeton 487
Ann Arbor 452
Dublin 374
Bologna 288
Bern 261
Lomé 211
Jacksonville 204
Nanjing 199
Westminster 199
Padova 180
Florence 149
Berlin 146
Sofia 139
Santa Clara 121
Saint Petersburg 110
Milan 109
Bremen 101
Amman 97
Turin 89
San Diego 83
Jinan 82
Frankfurt am Main 80
Shenyang 80
Nanchang 76
Redmond 76
Brescia 72
Beijing 70
Cesena 69
New York 63
Hebei 61
Rome 60
Changsha 58
Boardman 57
Des Moines 50
Falls Church 50
Abidjan 49
Medford 49
Jiaxing 44
Dearborn 43
Helsinki 42
Brussels 41
Pune 40
Tianjin 39
Mülheim 38
Redwood City 37
Hangzhou 31
Haikou 28
Amsterdam 27
Olalla 27
Los Angeles 26
Ningbo 25
Abeokuta 24
Norwalk 24
Paris 21
Toronto 19
Zhengzhou 19
Tokyo 18
Mahé 17
San Francisco 17
Taiyuan 16
Verona 15
Bühl 14
Chicago 14
Kuban 14
Kunming 14
London 14
Mountain View 14
Napoli 14
Guangzhou 13
São Paulo 13
Casalecchio di Reno 12
Fuzhou 11
Naples 11
Taizhou 11
Istanbul 10
Lanzhou 10
Courbevoie 9
Hanover 9
Leawood 9
Washington 9
Zanjan 9
Modena 8
Buffalo 7
Hyderabad 7
Lübeck 7
Melbourne 7
Moscow 7
Palermo 7
Phoenix 7
Totale 16.770
Nome #
DIABETE MELLITO TIPO 2 ED EVENTI ARITMICI NEL PAZIENTE ANZIANO. OSSERVAZIONI MEDIANTE MONITORAGGIO ECG HOLTER 533
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 297
Prognostic value of non-alcoholic fatty liver disease in the elderly patients 200
Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly 183
Accuracy of Lung Ultrasound in Patients with Acute Dyspnea: The Influence of Age, Multimorbidity and Cognitive and Motor Impairment 181
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 178
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 178
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 176
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 175
Prognostic role of nutritional status in elderly patients hospitalized for COVID-19: a monocentric study 173
Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial. 171
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 168
null 164
Effects of weight loss and risk factor treatment in subjects with elevated serum C3, an inflammatory predictor of myocardial infarction. 162
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 160
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 158
MARK-AGE population: From the human model to new insights 158
Aging and the burden of multimorbidity: Associations with inflammatory and anabolic hormonal biomarkers 156
Clinical Features Associated with Delirium Motor Subtypes in Older Inpatients: Results of a Multicenter Study 156
Adverse effects of proton pump inhibitors. 154
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 153
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 152
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 149
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 148
Association between accelerated multimorbidity and age-related cognitive decline in older Baltimore longitudinal study of aging participants without dementia. 147
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20 year multicentre experience. 144
Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia. 142
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 142
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 141
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 141
Albumin-induced hematocrit-lowering and B-type natriuretic peptide increase 140
Risk of Exclusion From Stroke Rehabilitation in the Oldest Old 138
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 137
Aging and Multimorbidity: New Tasks, Priorities, and Frontiers for Integrated Gerontological and Clinical Research 136
“Delirium Day”: a nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 136
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 134
Age dependency of regional impedance indices regardless of clinical stage in patients with cirrhosis of the liver 132
The Senile Lung as a Possible Source of Pitfalls on Chest Ultrasonography and Computed Tomography 132
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 132
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. 131
A Case of Acute Liver Failure during Ritonavir-Boosted Paritaprevir, Ombitasvir and Dasabuvir Therapy in a Patient with HCV Genotype 1b Cirrhosis 131
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 131
Psychological status and depression in patients with liver cirrhosis 130
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 129
A comparative assessment of C3 complement, C-reactive protein, leukocyte count and erythrocyte sedimentation rate as inflammatory markers of insulin resistance in an elderly population 129
Postprandial splanchnic haemodynamic changes in patients with liver cirrhosis and patent paraumbilical vein 128
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients. 127
Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. 126
Combination of the clock drawing test with the physical phenotype of frailty for the prediction of mortality and other adverse outcomes in older community dwellers without dementia 126
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 124
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 124
Clinical Role of Lung Ultrasound for the Diagnosis and Prognosis of Coronavirus Disease Pneumonia in Elderly Patients: A Pivotal Study 124
Plasma amino acid concentrations in patients with Amnestic Mild Cognitive Impairment or Alzheimer Disease 122
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 122
Metabolic disorders across hepatocellular carcinoma in Italy 121
null 121
Age as a possible Independent Prognostic Factor for Overall Survival and Recurrence-Free Survival after Transarterial Chemoembolization in Hepatocellular Carcinoma Patients 120
Serum C3 is a stronger inflammatory marker of insulin resistance than C reactive protein, leukocyte count, and erythrocyte sedimentation rate. Comparison study in an elderly population. 119
A simple scoring system for outcome prediction of ischemic stroke 119
Determinants of mean platelet volume (MPV) in an elderly population: Relevance of body fat, blood glucose and ischaemic electrocardiographic changes. 119
Physical Activity and Other Determinants of Survival in the Oldest Adults 119
Peliosis hepatis as an early histological finding in idiopathic portal hypertension: a case report. 119
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 119
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 118
Predictors of cognitive impairment assessed by Mini Mental State Examination in community-dwelling older adults: relevance of the step test 117
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 117
null 117
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 116
Liver hemangioma and vascular liver diseases in patients with systemic lupus erythematosus. 116
physical fitness and life extension : the pianoro study 114
Hepatic decompensation is the major driver of death In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. 114
Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies 113
Metabolic syndrome and all-cause mortality in older men and women. 113
Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension 113
Mortality after admission to stroke unit for intracerebral hemorrhage: Effect of age 80 and older and multimorbidity 113
Loss of weight in obese older adults: A biomarker of impending expansion of multimorbidity? 113
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 113
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 112
Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? 112
Age-specific rate of undiagnosed diabetes and prediabetes in acute stroke 112
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. 111
Bioavailable testosterone linearly declines over a wide age spectrum in men and women from the Baltimore longitudinal study of aging. 110
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 110
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 110
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 109
Torsade de pointes” during amiodarone infusion in cirrhotic woman with the prolonged QT interval. 109
Serum dehydroepiandrosterone sulfate and adverse health outcomes in older men and women. 108
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 108
EQ-5D as a predictor of mortality and hospitalization in elderly people. 107
Years of life that could be saved from prevention of hepatocellular carcinoma. 107
Renovascular impedance correlates with portal pressure in patients with liver cirrhosis 107
Metabolic syndrome in liver transplantation. Relation to etiology and immunosuppression 106
Favorevole evoluzione dello stato cognitivo nei pazienti trattati con statine dopo ictus ischemico 106
Clinical predictors of fever in stroke patients: Relevance of nasogastric tube 106
Physical activity is negatively associated with the metabolic syndrome in the elderly 106
Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma 105
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype 105
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. 105
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 105
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 104
Totale 13.624
Categoria #
all - tutte 63.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.904 0 0 49 307 612 614 787 762 854 410 211 298
2020/20213.702 648 218 98 226 144 127 90 165 291 208 150 1.337
2021/20224.701 385 141 279 289 421 258 140 287 216 289 1.233 763
2022/20235.725 572 916 289 736 282 405 198 311 881 149 541 445
2023/20241.682 104 241 100 157 179 343 79 83 93 107 93 103
2024/20251.248 265 863 120 0 0 0 0 0 0 0 0 0
Totale 24.907